Keywords: Tumors (Pre-Treatment), Cancer
Motivation: δ-catenin is the only member of the p120ctn family that can be expressed in neurons. It has been confirmed that δ-catenin highly expressed in breast cancer patients and is significantly associated with the poor prognosis.
Goal(s): Explore the changes of brain network function in BRCA patients with different expressions of δ-catenin before treatment.
Approach: Categorize untreated BRCA patients into two groups based on the different expressions of δ-catenin,and subjected to neuropsychological testing, brain structural and functional MRI, along with a healthy control group.
Results: The breast cancer patients with different δ-catenin expression have different effects on the indexes of brain functional network.
Impact: The research results suggest that the brain-network changes caused by δ-catenin precede cognitive impairment changes. Early brain damage caused by δ-catenin protein may involve areas related to executive functions and emotional regulation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords